Providing for consideration of the bill (H.R. 999) to protect an individual's ability to access contraceptives and to engage in contraception and to protect a health care providers ability to provide contraceptives, contraception, and information related to contraception.
- Last Action
- 6/9/2026
Actions
- 2025-01-31Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2025-01-31Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2025-01-31Introduced in House
- 2025-01-31Introduced in House
CRS Summary
As of 2025-01-31 (00)
Save Americans from the Fentanyl Emergency Act or the SAFE Act
This bill permanently places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act. Fentanyl-related substances are currently regulated under schedule I through a temporary order issued by the Drug Enforcement Administration. The temporary order expires on March 31, 2025.
It limits mandatory minimum penalties for certain offenses involving fentanyl-related substances, establishes a process to deschedule or remove certain fentanyl-related substances that have a low potential for abuse, and allows federal courts to vacate or reduce sentences for convictions involving a fentanyl-related substance that is descheduled or moved to a schedule other than schedule I or II.
The bill establishes a new, alternative registration process for schedule I research. It also makes other changes to registration requirements for conducting research with controlled substances, including
- permitting a single registration for related research sites in certain circumstances,
- waiving the requirement for a new inspection in certain situations, and
- allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration.
Finally, the bill requires the Government Accountability Office to analyze the implementation and impact of permanently placing fentanyl-related substances into schedule I of the Controlled Substances Act.
Cosponsors (17)
- Maria Salazar (R-FL)
- Dan Newhouse (R-WA)
- Jason Crow (D-CO)
- Chrissy Houlahan (D-PA)
- Shomari Figures (D-AL)
- Angie Craig (D-MN)
- Jennifer McClellan (D-VA)
- Nikki Budzinski (D-IL)
- Johnny Olszewski (D-MD)
- Scott Peters (D-CA)
- Gerald Connolly (D-VA)
- Gilbert Cisneros (D-CA)
- Sharice Davids (D-KS)
- Raul Ruiz (D-CA)
- Ami Bera (D-CA)
- Brian Fitzpatrick (R-PA)
- Seth Magaziner (D-RI)
Subjects
- Administrative law and regulatory procedures
- Congressional oversight
- Criminal procedure and sentencing
- Department of Justice
- Drug trafficking and controlled substances
- Government studies and investigations
- International law and treaties
- Licensing and registrations
- Manufacturing
- Research administration and funding
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.